Tag: mrna

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (nanx avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: nan% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.12)

    MRNA — MILD BEARISH (-0.12)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.123 Confidence Medium
    Buzz Volume 18 articles (1.0x avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.15 |
    IV Percentile: 0% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel Review
    on 2026-06-18

  • MRNA — MILD BEARISH (-0.14)

    MRNA — MILD BEARISH (-0.14)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.144 Confidence Medium
    Buzz Volume 14 articles (1.0x avg) Category Regulatory
    Sources 2 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.14 |
    IV Percentile: 50% |
    Signal: 0.35

    Forward Event Detected
    Fda Panel
    on 2026-06-18

  • MRNA — NEUTRAL (-0.08)

    MRNA — NEUTRAL (-0.08)

    NOISE

    Sentiment analysis complete.

    Composite Score -0.082 Confidence Low
    Buzz Volume 19 articles (1.0x avg) Category Other
    Sources 2 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.00 |
    IV Percentile: 50% |
    Signal: 0.35

    Forward Event Detected
    Fda Advisory Panel Review
    on 2026-06-18

  • MRNA — NEUTRAL (+0.05)

    MRNA — NEUTRAL (0.05)

    NOISE

    Sentiment analysis complete.

    Composite Score 0.055 Confidence Medium
    Buzz Volume 27 articles (1.0x avg) Category Other
    Sources 3 distinct Conviction 0.00
    Options Market
    P/C Ratio: 0.21 |
    IV Percentile: 50% |
    Signal: 0.35

    Forward Event Detected
    Fda Advisory Panel Review
    on 2026-06-18